As of March 2025 Galectin Therapeutics has a market cap of €97.76 Million. This makes Galectin Therapeutics the world's 8966th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Mar 3rd, 2025 the market cap of Galectin Therapeutics was reported to be: